Hangzhou Wensli Silk Culture
301066
Yoantion Industrial Inc.,
301053
Xinlei Compressor
301317
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
688621 Beijing Sun-Novo Pharmaceutical Research
- 45.97
- 0.000.00%
Market Closed Apr 24 15:00 CST
5.15BMarket Cap38.34P/E (TTM)
0.00High0.00Low0lotVolume0.00Open45.97Pre Close0.00Turnover0.00%Turnover Ratio29.02P/E (Static)112.00MShares57.4152wk High5.00P/B5.15BFloat Cap28.9052wk Low55.16Limit Up112.00MShs Float133.50Historical High36.78Limit Down0.00%Amplitude28.90Historical Low0.17Dividend TTM--Avg Price0lotAsk0.36%Div YieldTTM100Lot Size0lotBid
Beijing Sun-Novo Pharmaceutical Research Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -8.49%230.84M | 15.70%1.08B | 32.47%916.68M | 22.08%562.86M | 8.53%252.26M | 37.76%932.12M | 39.73%692M | 42.16%461.05M | 57.09%232.43M | 37.06%676.61M |
| Operating revenue | -8.49%230.84M | 15.70%1.08B | 32.47%916.68M | 22.08%562.86M | 8.53%252.26M | 37.76%932.12M | 39.73%692M | 42.16%461.05M | 57.09%232.43M | 37.06%676.61M |
| Total operating cost | 14.70%197.75M | 26.97%872.21M | 38.04%670.05M | 22.52%388.53M | 0.68%172.41M | 35.63%686.94M | 37.45%485.4M | 40.68%317.12M | 58.75%171.24M | 38.22%506.49M |
| Operating cost | 20.96%123.34M | 33.08%537.33M | 44.38%438.66M | 24.75%247.73M | -13.50%101.97M | 34.08%403.77M | 42.38%303.83M | 47.08%198.59M | 83.54%117.88M | 30.95%301.15M |
| Operating tax surcharges | 449.52%1.86M | 60.39%2M | 42.83%1.23M | 36.27%617.62K | 189.70%338.54K | 11.84%1.25M | 2.79%863.09K | -18.84%453.25K | -65.75%116.86K | 122.41%1.12M |
| Operating expense | -3.98%8.17M | 0.80%44.14M | 56.71%30.4M | 47.37%17.45M | 29.22%8.51M | 116.01%43.79M | 34.95%19.4M | 19.81%11.84M | 25.20%6.59M | 19.04%20.27M |
| Administration expense | -1.54%24.28M | -2.88%106.3M | -2.82%72.7M | -3.60%48.92M | -7.21%24.66M | 20.88%109.45M | 14.60%74.81M | 20.95%50.75M | 32.67%26.58M | 31.99%90.54M |
| Financial expense | 20.60%2.36M | 110.11%10.5M | 124.45%7.55M | 121.88%4.71M | 160.75%1.96M | 33.92%5M | 31.46%3.36M | 14.24%2.12M | -38.26%751.62K | 34.75%3.73M |
| -Interest expense (Financial expense) | -22.02%3.22M | 32.26%16.11M | 47.01%12.13M | 59.87%8.35M | 76.29%4.13M | 25.55%12.18M | 14.89%8.25M | 12.82%5.22M | 61.95%2.34M | 172.10%9.7M |
| -Interest Income (Financial expense) | 57.32%-931.94K | 21.71%-5.67M | 6.09%-4.63M | -17.14%-3.67M | -35.76%-2.18M | -17.69%-7.24M | -5.91%-4.93M | -12.06%-3.13M | -61.77%-1.61M | -630.90%-6.15M |
| Research and development | 7.90%37.73M | 39.02%171.94M | 43.76%119.51M | 29.48%69.09M | 80.85%34.97M | 37.91%123.68M | 46.61%83.13M | 47.71%53.36M | 15.14%19.33M | 88.51%89.69M |
| Credit Impairment Loss | -65.95%-21.71M | 26.42%-44.28M | -18.17%-34.19M | -33.01%-26.91M | -28.12%-13.08M | -209.52%-60.18M | -102.62%-28.94M | -143.97%-20.23M | -142.07%-10.21M | -74.55%-19.44M |
| Other net revenue | ||||||||||
| Invest income | 338.06%697.61K | -240.93%-1.82M | -33.83%317.92K | -27.48%232.92K | -0.04%159.25K | -50.80%1.29M | -81.05%480.43K | -87.13%321.18K | -90.44%159.31K | 55.93%2.62M |
| -Including: Investment income associates | ---- | ---4.68M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset deal income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2,554.54%-36.82K |
| Other revenue | 51.52%11.36M | 122.86%17.53M | 75.86%9.35M | 91.35%8.69M | 462.24%7.5M | -50.89%7.87M | -34.37%5.32M | -3.57%4.54M | 32.96%1.33M | 230.97%16.02M |
| Operating profit | -68.51%23.44M | -8.48%177.69M | 21.06%222.11M | 21.62%156.34M | 41.85%74.43M | 14.70%194.16M | 32.51%183.47M | 31.44%128.56M | 36.14%52.47M | 38.08%169.27M |
| Add:Non operating Income | -99.89%2.11 | 83.25%18.47K | -76.74%2.01K | -61.07%2K | 75.70%2K | -89.49%10.08K | 4.46%8.63K | -17.87%5.14K | -99.14%1.14K | 88.80%95.87K |
| Less:Non operating expense | 38.22%169.73K | 122.07%1.72M | 215.93%1.58M | 2,173.89%1.53M | 134.19%122.8K | 233.66%774.6K | 167.15%499.9K | 1,722.63%67.21K | 6,976.76%52.44K | -57.06%232.15K |
| Total profit | -68.68%23.27M | -9.00%175.99M | 20.52%220.53M | 20.49%154.82M | 41.76%74.31M | 14.34%193.4M | 32.32%182.98M | 31.37%128.49M | 35.55%52.42M | 38.52%169.14M |
| Less:Income tax cost | -173.27%-4.08M | -33.59%6.97M | 61.95%16.73M | 46.65%13.47M | 23.13%5.57M | 0.65%10.5M | 30.36%10.33M | -14.60%9.19M | 17.91%4.52M | -21.60%10.43M |
| Net profit | -60.21%27.35M | -7.59%169.01M | 18.04%203.8M | 18.47%141.35M | 43.52%68.74M | 15.24%182.9M | 32.44%172.65M | 37.05%119.31M | 37.49%47.9M | 45.88%158.7M |
| Net profit from continuing operation | -60.21%27.35M | -7.59%169.01M | 18.04%203.8M | 18.47%141.35M | 43.52%68.74M | 15.24%182.9M | 32.44%172.65M | 37.05%119.31M | 37.49%47.9M | 45.88%158.7M |
| Less:Minority Profit | 44.48%-2.23M | -350.84%-8.4M | -347.27%-3.89M | -649.40%-7.22M | -10,351.48%-4.01M | -183.48%-1.86M | 8.28%1.57M | 503.24%1.31M | -102.67%-38.38K | -28.71%2.23M |
| Net profit of parent company owners | -59.34%29.58M | -3.98%177.41M | 21.40%207.69M | 25.91%148.57M | 51.77%72.75M | 18.08%184.76M | 32.72%171.08M | 35.03%117.99M | 43.52%47.94M | 48.09%156.47M |
| Earning per share | ||||||||||
| Basic earning per share | -59.09%0.27 | -4.24%1.58 | 20.92%1.85 | 26.67%1.33 | 53.49%0.66 | 17.86%1.65 | 33.04%1.53 | 34.62%1.05 | 2.38%0.43 | -7.28%1.4 |
| Diluted earning per share | -59.09%0.27 | -4.24%1.58 | 20.92%1.85 | 26.67%1.33 | 53.49%0.66 | 17.86%1.65 | 33.04%1.53 | 34.62%1.05 | 2.38%0.43 | -7.28%1.4 |
| Other composite income | ||||||||||
| Total composite income | -60.21%27.35M | -7.59%169.01M | 18.04%203.8M | 18.47%141.35M | 43.52%68.74M | 15.24%182.9M | 32.44%172.65M | 37.05%119.31M | 37.49%47.9M | 45.88%158.7M |
| Total composite income of parent company owners | -59.34%29.58M | -3.98%177.41M | 21.40%207.69M | 25.91%148.57M | 51.77%72.75M | 18.08%184.76M | 32.72%171.08M | 35.03%117.99M | 43.52%47.94M | 48.09%156.47M |
| Total composite income of minority owners | 44.48%-2.23M | -350.84%-8.4M | -347.27%-3.89M | -649.40%-7.22M | -10,351.48%-4.01M | -183.48%-1.86M | 8.28%1.57M | 503.24%1.31M | -102.67%-38.38K | -28.71%2.23M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.